JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on March 14, 2006; DOI: 10.1124/jpet.105.095810


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.095810v1
317/3/1337    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jutkiewicz, E. M.
Right arrow Articles by Woods, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jutkiewicz, E. M.
Right arrow Articles by Woods, J. H.


Received for publication September 20, 2005.
Revised February 28, 2006.
Accepted for publication February 28, 2006.

The convulsive and electroencephalographic changes produced by nonpeptidic delta-opioid agonists in rats: comparison with pentylenetetrazol

Emily M. Jutkiewicz 1*, Michelle G. Baladi 1, John E. Folk 2, Kenner C. Rice 2, James H. Woods 3

1 University of Michigan 2 NIH- NIDDK 3 University of Michigan Medical School

* Address correspondence to: E-mail: ejutkiew{at}umich.edu

Abstract

Delta-opioid agonists produce convulsions and antidepressant-like effects in rats. It has been suggested that the antidepressant-like effects are produced through a convulsant mechanism of action either through overt convulsions or nonconvulsive seizures. This study evaluated the convulsive and seizurogenic effects of nonpeptidic delta-opioid agonists at doses that previously were reported to produce antidepressant-like effects. In addition, delta-opioid agonist-induced electroencephalographic (EEG) and behavioral changes were compared with those produced by the chemical convulsant pentylenetetrazol (PTZ). For these studies, EEG changes were recorded using a telemetry system before and following injections of the delta-opioid agonists SNC80 and (+)BW373U86. Acute administration of nonpeptidic delta-opioid agonists produced bilateral ictal and paroxysmal spike and/or sharp wave discharges. Delta-opioid agonists produced brief changes in EEG recordings, and tolerance rapidly developed to these effects; however, PTZ produced longer-lasting EEG changes that were exacerbated following repeated administration. Studies with antiepileptic drugs demonstrated that compounds used to treat absence epilepsy blocked the convulsive effects of nonpeptidic delta-opioid agonists. Overall, these data suggest that delta-opioid agonist-induced EEG changes are not required for the antidepressant-like effects of these compounds and that neural circuitry involved in absence epilepsy may be related to delta-opioid agonist-induced convulsions. In terms of therapeutic development, these data suggest that it may be possible to develop delta-opioid agonists devoid of convulsive properties.


Key words: antiepileptic drugs, convulsions, delta-opioid agonists, electroencephalogram, rats, seizures


This article has been cited by other articles:


Home page
Mol. Interv.Home page
E. M. Jutkiewicz
The Antidepressant -like Effects of Delta-Opioid Receptor Agonists
Mol. Interv., June 1, 2006; 6(3): 162 - 169.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.